|
|
1.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
2.
|
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives. MedStar authors:
- Bhatt, Meghna
- Kazi, Sadaf
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Pharmacogenomics. 24(16):859-870, 2023 Nov.
Institution:
- MedStar Institute for Innovation
- MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- MedStar Health
- National Center for Human Factors in Healthcare
- Pharmacogenomics
- Pharmacy Residency
Medline publication type:
All authors: - Bhatt M, Peshkin BN, Kazi S, Schwartz MD, Ashai N, Swain SM, Smith DM
|
